MedPath

VEGZELMA

VEGZELMA

Approved
DIN Number

02534185

Drug Class

Human

Market Date

May 1, 2023

Company
HC

Celltrion Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02534185
AIG Number0151381001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FG01 BEVACIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BEVACIZUMABActive
Strength: 400 MG / 16 ML
Monograph: BEVACIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.